Claim verdict
Experimental pipeline
“VRX-0075 is more powerful than retatrutide in humans.”
This verdict applies to the exact claim above. It is not a verdict on the compound overall, a safety guarantee, or a recommendation to use it.
Registry verdict
Unsupported as worded — the only comparison is in rats.
Why this verdict
- The comparison people are quoting comes from a 2026 conference abstract describing a rodent obesity model, not a human study.
- No human has been given VRX-0075 in our curated record, so there is no human efficacy, tolerability or safety data to compare with retatrutide's Phase 3 results.
- Animal weight change routinely fails to predict human weight change, dosing, or tolerability. Many compounds that outperformed a comparator in rodents did not do so in people.
- Unsupported here means the evidence needed does not exist yet — not that the molecule has been shown to be worse.